{name}
{subtitle}
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)
city
~7 mi. (Grand Rapids, Michigan, +144 more cities)
facility
Cancer & Hematology Centers of Western Michigan ( Site 0018)
drug
belzutifan, +3 more drugs
drug type
immunotherapy, +1 more type
A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)
city
~7 mi. (Grand Rapids, Michigan, +126 more cities)
facility
Research Site
biomarker
ER Positive, +2 more biomarkers
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
city
~7 mi. (Grand Rapids, Michigan, +523 more cities)
facility
Spectrum Health at Butterworth Campus
drug
cabozantinib, +2 more drugs
drug type
immunotherapy, +1 more type
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy
city
~7 mi. (Grand Rapids, Michigan, +744 more cities)
facility
Helen DeVos Children's Hospital at Spectrum Health, +2 more facilities
drug type
radiation therapy, +1 more type
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
city
~7 mi. (Grand Rapids, Michigan, +226 more cities)
facility
Cancer & Hematology Centers of Western Michigan ( Site 0013)
drug
enzalutamide, +1 more drug
drug type
hormone therapy, +1 more type
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
city
~7 mi. (Grand Rapids, Michigan, +454 more cities)
facility
Spectrum Health at Butterworth Campus, +1 more facility
drug
brentuximab vedotin, +7 more drugs
drug type
chemotherapy, +3 more types
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~7 mi. (Grand Rapids, Michigan, +825 more cities)
facility
Helen DeVos Children's Hospital at Spectrum Health, +2 more facilities
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
city
~7 mi. (Grand Rapids, Michigan, +240 more cities)
facility
Spectrum Health at Butterworth Campus
condition
Endometrial Adenocarcinoma, +5 more conditions
drug
carboplatin, +2 more drugs
drug type
chemotherapy, +1 more type